Cell entry of cell penetrating peptides: Tales of tails wagging dogs

Journal of Controlled Release

Volumn 161, Issue 2, 2012, Pages 582-591

  Jones, Arwyn T ^a   Sayers, Edward J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cell penetrating peptides (CPPs); Fluorophores; Peptide therapeutics; Photostimulation; Plasma membrane

Indexed keywords

CELL-PENETRATING PEPTIDE; ENDOCYTIC PATHWAYS; EXPERIMENTAL PROTOCOLS; EXTRACELLULAR; FLUORESCENT PROBES; HIGHER EFFICIENCY; HIV-TAT; IN-VITRO; MACROMOLECULAR STRUCTURES; MEMBRANE TRANSLOCATION; PENETRATIN; PEPTIDE SEQUENCES; PEPTIDE THERAPEUTICS; PHOTOSTIMULATION; SMALL MOLECULES;

CELL MEMBRANES; FLUOROPHORES; MACROMOLECULES; PEPTIDES;

CYTOLOGY;

CELL PENETRATING PEPTIDE; CYSTEINE; DELCASERTIB; DISULFIDE; FLUORESCENT DYE; HIV TAT PROTEIN; LIPID; OCTAARGININE; PENETRATIN; SMALL INTERFERING RNA; SUGAR; TRANSPORTAN; TRYPTOPHAN; UNCLASSIFIED DRUG; XG 102;

AMINO ACID SEQUENCE; ARTIFACT; CANCER CELL CULTURE; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CELL TRANSPORT; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; HEARING LOSS; HUMAN; HYDROPHOBICITY; LIPID TRANSPORT; LIPIDATION; MEMBRANE DAMAGE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA VECTOR; STROKE;

ANIMALS; CELL-PENETRATING PEPTIDES; CYSTEINE; DRUG CARRIERS; FLUORESCENT DYES; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PEPTIDES; PROTEIN TRANSPORT;

EID: 84862674370     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.04.003     Document Type: Review

References (137)

1. R.G. Ptak, W. Fu, B.E. Sanders-Beer, J.E. Dickerson, J.W. Pinney, D.L. Robertson, M.N. Rozanov, K.S. Katz, D.R. Maglott, K.D. Pruitt, C.W. Dieffenbach, Cataloguing the HIV type 1 human protein interaction network, AIDS Res. Hum. Retroviruses 24 (2008) 1497-1502.
2. P. Lundberg, U. Langel, A brief introduction to cell-penetrating peptides, J. Mol. Recognit. 16 (2003) 227-233.
3. H. Raghuraman, A. Chattopadhyay, Melittin: a membrane-active peptide with diverse functions, Biosci. Rep. 27 (2007) 189-223.
4. S. Jones, J. Howl, Biological applications of the receptor mimetic peptide mastoparan, Curr. Protein Pept. Sci. 7 (2006) 501-508.
5. S.T. Henriques, M.N. Melo, M.A. Castanho, Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 399 (2006) 1-7.
6. K. Splith, I. Neundorf, Antimicrobial peptides with cell-penetrating peptide properties and vice versa, Eur. Biophys. J. 40 (2011) 387-397.
7. M. Rhee, P. Davis, Mechanism of uptake of C105Y, a novel cell-penetrating peptide, J. Biol. Chem. 281 (2006) 1233-1240.
8. Y.Z. Lin, S.Y. Yao, R.A. Veach, T.R. Torgerson, J. Hawiger, Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence, J. Biol. Chem. 270 (1995) 14255-14258.
9. L. Crombez, G. Aldrian-Herrada, K. Konate, Q.N. Nguyen, G.K. McMaster, R. Brasseur, F. Heitz, G. Divita, A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells, Mol. Ther. 17 (2009) 95-103.
10. K. Konno, M. Hisada, H. Naoki, Y. Itagaki, N. Kawai, A. Miwa, T. Yasuhara, Y. Morimoto, Y. Nakata, Structure and biological activities of eumenine mastoparan-AF (EMP-AF), a new mast cell degranulating peptide in the venom of the solitary wasp (Anterhynchium flavomarginatum micado), Toxicon 38 (2000) 1505-1515.
11. J. Oehlke, A. Scheller, B. Wiesner, E. Krause, M. Beyermann, E. Klauschenz, M. Melzig, M. Bienert, Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically, Biochim. Biophys. Acta 1414 (1998) 127-139.
12. U. Soomets, M. Lindgren, X. Gallet, M. Hallbrink, A. Elmquist, L. Balaspiri, M. Zorko, M. Pooga, R. Brasseur, U. Langel, Deletion analogues of transportan, Biochim. Biophys. Acta 1467 (2000) 165-176.
13. M. Pooga, M. Hallbrink, M. Zorko, U. Langel, Cell penetration by transportan, FASEB J. 12 (1998) 67-77.
14. N.K. Subbarao, R.A. Parente, F.C. Szoka Jr., L. Nadasdi, K. Pongracz, pH-dependent bilayer destabilization by an amphipathic peptide, Biochemistry 26 (1987) 2964-2972.
15. Y.K. Reshetnyak, O.A. Andreev, M. Segala, V.S. Markin, D.M. Engelman, Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 15340-15345.
16. T.B. Wyman, F. Nicol, O. Zelphati, P.V. Scaria, C. Plank, F.C. Szoka Jr., Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers, Biochemistry 36 (1997) 3008-3017.
17. C.E. Dempsey, The actions of melittin on membranes, Biochim. Biophys. Acta 1031 (1990) 143-161.
18. M.C. Morris, P. Vidal, L. Chaloin, F. Heitz, G. Divita, A new peptide vector for efficient delivery of oligonucleotides into mammalian cells, Nucleic Acids Res. 25 (1997) 2730-2736.
19. A. Elmquist, M. Lindgren, T. Bartfai, U. Langel, VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions, Exp. Cell Res. 269 (2001) 237-244.
20. D. Derossi, A.H. Joliot, G. Chassaing, A. Prochiantz, The third helix of the Antennapedia homeodomain translocates through biological membranes, J. Biol. Chem. 269 (1994) 10444-10450.
21. S. Deshayes, A. Heitz, M.C. Morris, P. Charnet, G. Divita, F. Heitz, Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis, Biochemistry 43 (2004) 1449-1457.
22. K. Takayama, I. Nakase, H. Michiue, T. Takeuchi, K. Tomizawa, H. Matsui, S. Futaki, Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas), J. Control. Release 138 (2009) 128-133.
23. M.H. Nelson, D.A. Stein, A.D. Kroeker, S.A. Hatlevig, P.L. Iversen, H.M. Moulton, Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity, Bioconjug. Chem. 16 (2005) 959-966.
24. E. Esteve, K. Mabrouk, A. Dupuis, S. Smida-Rezgui, X. Altafaj, D. Grunwald, J.C. Platel, N. Andreotti, I. Marty, J.M. Sabatier, M. Ronjat, M. De Waard, Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane, J. Biol. Chem. 280 (2005) 12833-12839.
25. I. Martin, M. Teixido, E. Giralt, Design, synthesis and characterization of a new anionic cell-penetrating peptide: SAP(E), Chembiochem 12 (2011) 896-903.
26. J.R. Maiolo, M. Ferrer, E.A. Ottinger, Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides, Biochim. Biophys. Acta 1712 (2005) 161-172.
27. T. Sugita, T. Yoshikawa, Y. Mukai, N. Yamanada, S. Imai, K. Nagano, Y. Yoshida, H. Shibata, Y. Yoshioka, S. Nakagawa, H. Kamada, S.I. Tsunoda, Y. Tsutsumi, Comparative study on transduction and toxicity of protein transduction domains, Br. J. Pharmacol. 153 (2008) 1143-1152.
28. E. Vives, P. Brodin, B. Lebleu, A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem. 272 (1997) 16010-16017.
29. J.B. Rothbard, S. Garlington, Q. Lin, T. Kirschberg, E. Kreider, P.L. McGrane, P.A. Wender, P.A. Khavari, Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation, Nat. Med. 6 (2000) 1253-1257.
30. K. Ezzat, S.E. Andaloussi, E.M. Zaghloul, T. Lehto, S. Lindberg, P.M. Moreno, J.R. Viola, T. Magdy, R. Abdo, P. Guterstam, R. Sillard, S.M. Hammond, M.J. Wood, A.A. Arzumanov, M.J. Gait, C.I. Smith, M. Hallbrink, U. Langel, PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation, Nucleic Acids Res. 39 (2011) 5284-5298.
31. M.J. May, F. D'Acquisto, L.A. Madge, J. Glockner, J.S. Pober, S. Ghosh, Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex, Science 289 (2000) 1550-1554.
32. J.S. Wadia, R.V. Stan, S.F. Dowdy, Transducible Tat-HA fusogenic peptide enhances escape of Tat-fusion proteins after lipid raft macropinocytosis, Nat. Med. 10 (2004) 310-315.
33. A.S. Buchau, D.T. MacLeod, S. Morizane, P.F. Kotol, T. Hata, R.L. Gallo, Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytes, J. Invest. Dermatol. 129 (2009) 2148-2155.
34. T. Letoha, C. Somlai, T. Takacs, A. Szabolcs, K. Jarmay, Z. Rakonczay Jr., P. Hegyi, I. Varga, J. Kaszaki, I. Krizbai, I. Boros, E. Duda, E. Kusz, B. Penke, A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis, World J. Gastroenterol. 11 (2005) 990-999.
35. I. Nakase, M. Niwa, T. Takeuchi, K. Sonomura, N. Kawabata, Y. Koike, M. Takehashi, S. Tanaka, K. Ueda, J.C. Simpson, A.T. Jones, Y. Sugiura, S. Futaki, Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement, Mol. Ther. 10 (2004) 1011-1022.
36. S.K. Kolluri, X. Zhu, X. Zhou, B. Lin, Y. Chen, K. Sun, X. Tian, J. Town, X. Cao, F. Lin, D. Zhai, S. Kitada, F. Luciano, E. O'Donnell, Y. Cao, F. He, J. Lin, J.C. Reed, A.C. Satterthwait, X.K. Zhang, A short Nur77-derived peptide converts Bcl-2 from a protector to a killer, Cancer Cell 14 (2008) 285-298.
37. J.L. Cohen, A. Almutairi, J.A. Cohen, M. Bernstein, S.L. Brody, D.P. Schuster, J.M. Frechet, Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides, Bioconjug. Chem. 19 (2008) 876-881.
38. N.A. Brooks, D.S. Pouniotis, C.K. Tang, V. Apostolopoulos, G.A. Pietersz, Cell-penetrating peptides: application in vaccine delivery, Biochim. Biophys. Acta 1805 (2010) 25-34.
39. T. Endoh, T. Ohtsuki, Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape, Adv. Drug Deliv. Rev. 61 (2009) 704-709.
40. C. Foged, H.M. Nielsen, Cell-penetrating peptides for drug delivery across membrane barriers, Expert Opin. Drug Deliv. 5 (2008) 105-117.
41. M. Grdisa, The delivery of biologically active (therapeutic) peptides and proteins into cells, Curr. Med. Chem. 18 (2011) 1373-1379.
42. M. Jafari, P. Chen, Peptide mediated siRNA delivery, Curr. Top. Med. Chem. 9 (2009) 1088-1097.
43. R.M. Johnson, S.D. Harrison, D. Maclean, Therapeutic applications of cell-penetrating peptides, Methods Mol. Biol. 683 (2011) 535-551.
44. K.M. Stewart, K.L. Horton, S.O. Kelley, Cell-penetrating peptides as delivery vehicles for biology and medicine, Org. Biomol. Chem. 6 (2008) 2242-2255.
45. V.P. Torchilin, Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery, Biopolymers 90 (2008) 604-610.
46. V. Kersemans, K. Kersemans, B. Cornelissen, Cell penetrating peptides for in vivo molecular imaging applications, Curr. Pharm. Des. 14 (2008) 2415-2447.
47. A. Chugh, F. Eudes, Cellular uptake of cell-penetrating peptides pVEC and transportan in plants, J. Pept. Sci. 14 (2008) 477-481.
48. N. Nekhotiaeva, A. Elmquist, G.K. Rajarao, M. Hallbrink, U. Langel, L. Good, Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides, FASEB J. 18 (2004) 394-396.
49. W.J. Ryves, A.J. Harwood, Use of a penetratin-linked peptide in Dictyostelium, Mol. Biotechnol. 33 (2006) 123-132.
50. S. Futaki, S. Goto, Y. Sugiura, Membrane permeability commonly shared among arginine-rich peptides, J. Mol. Recognit. 16 (2003) 260-264.
51. S. Futaki, I. Nakase, A. Tadokoro, T. Takeuchi, A.T. Jones, Arginine-rich peptides and their internalization mechanisms, Biochem. Soc. Trans. 35 (2007) 784-787.
52. G. Lattig-Tunnemann, M. Prinz, D. Hoffmann, J. Behlke, C. Palm-Apergi, I. Morano, H.D. Herce, M.C. Cardoso, Backbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptides, Nat. Commun. 2 (2011) 453.
53. C.L. Watkins, P. Brennan, C. Fegan, K. Takayama, I. Nakase, S. Futaki, A.T. Jones, Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD, J. Control. Release 140 (2009) 237-244.
54. A.T. Jones, Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides, Int. J. Pharm. 354 (2008) 34-38.
55. F. Madani, S. Lindberg, U. Langel, S. Futaki, A. Graslund, Mechanisms of cellular uptake of cell-penetrating peptides, J. Biophys. 2011 (2011) 414729.
56. H. Raagel, P. Saalik, M. Pooga, Peptide-mediated protein delivery-which pathways are penetrable? Biochim. Biophys. Acta 1798 (2010) 2240-2248.
57. G.J. Doherty, H.T. McMahon, Mechanisms of endocytosis, Annu. Rev. Biochem. 78 (2009) 857-902.
58. J. Huotari, A. Helenius, Endosome maturation, EMBO J. 30 (2011) 3481-3500.
59. M. Lundberg, S. Wikstrom, M. Johansson, Cell surface adherence and endocytosis of protein transduction domains, Mol. Ther. 8 (2003) 143-150.
60. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, B. Lebleu, Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake, J. Biol. Chem. 278 (2003) 585-590.
61. M. Kosuge, T. Takeuchi, I. Nakase, A.T. Jones, S. Futaki, Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans, Bioconjug. Chem. 19 (2008) 656-664.
62. S.T. Gammon, V.M. Villalobos, J.L. Prior, V. Sharma, D. Piwnica-Worms, Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake, Bioconjug. Chem. 14 (2003) 368-376.
63. C. Palm, M. Jayamanne, M. Kjellander, M. Hallbrink, Peptide degradation is a critical determinant for cell-penetrating peptide uptake, Biochim. Biophys. Acta 1768 (2007) 1769-1776.
64. M. Hallbrink, J. Oehlke, G. Papsdorf, M. Bienert, Uptake of cell-penetrating peptides is dependent on peptide-to-cell ratio rather than on peptide concentration, Biochim. Biophys. Acta 1667 (2004) 222-228.
65. G. Tunnemann, G. Ter-Avetisyan, R.M. Martin, M. Stockl, A. Herrmann, M.C. Cardoso, Live-cell analysis of cell penetration ability and toxicity of oligoarginines, J. Pept. Sci. 14 (2008) 469-476.
66. S. Al-Taei, N.A. Penning, J.C. Simpson, S. Futaki, T. Takeuchi, I. Nakase, A.T. Jones, Intracellular traffic and fate of protein transduction domains HIV-1 Tat peptide and octaarginine. Implications for their utilization as drug delivery vectors, Bioconjug. Chem. 17 (2006) 90-100.
67. M.M. Fretz, N.A. Penning, S. Al-Taei, S. Futaki, T. Takeuchi, I. Nakase, G. Storm, A.T. Jones, Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells, Biochem. J. 403 (2007) 335-342.
68. C.L. Watkins, D. Schmaljohann, S. Futaki, A.T. Jones, Low concentration thresholds of plasma membranes for rapid energy-independent translocation of a cell-penetrating peptide, Biochem. J. 420 (2009) 179-189.
69. F. Duchardt, M. Fotin-Mleczek, H. Schwarz, R. Fischer, R. Brock, A comprehensive model for the cellular uptake of cationic cell-penetrating peptides, Traffic 8 (2007) 848-866.
70. H.D. Herce, A.E. Garcia, Cell penetrating peptides: how do they do it? J. Biol. Phys. 33 (2007) 345-356.
71. D.J. Mitchell, D.T. Kim, L. Steinman, C.G. Fathman, J.B. Rothbard, Polyarginine enters cells more efficiently than other polycationic homopolymers, J. Pept. Res. 56 (2000) 318-325.
72. P.E. Thoren, D. Persson, P. Isakson, M. Goksor, A. Onfelt, B. Norden, Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells, Biochem. Biophys. Res. Commun. 307 (2003) 100-107.
73. C. Palm-Apergi, A. Lorents, K. Padari, M. Pooga, M. Hallbrink, The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake, FASEB J. 23 (2009) 214-223.
74. M. Fotin-Mleczek, S. Welte, O. Mader, F. Duchardt, R. Fischer, H. Hufnagel, P. Scheurich, R. Brock, Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization, J. Cell Sci. 118 (2005) 3339-3351.
75. A. Kloss, P. Henklein, D. Siele, M. Schmolke, S. Apcher, L. Kuehn, P.W. Sheppard, B. Dahlmann, The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities, Eur. J. Pharm. Biopharm. 72 (2009) 219-225.
76. W.P. Verdurmen, R. Brock, Biological responses towards cationic peptides and drug carriers, Trends Pharmacol. Sci. 32 (2011) 116-124.
77. K. Saar, M. Lindgren, M. Hansen, E. Eiriksdottir, Y. Jiang, K. Rosenthal-Aizman, M. Sassian, U. Langel, Cell-penetrating peptides: a comparative membrane toxicity study, Anal. Biochem. 345 (2005) 55-65.
78. C.Y. Jiao, D. Delaroche, F. Burlina, I.D. Alves, G. Chassaing, S. Sagan, Translocation and endocytosis for cell-penetrating peptide internalization, J. Biol. Chem. 284 (2009) 33957-33965.
79. A. Subrizi, E. Tuominen, A. Bunker, T. Rog, M. Antopolsky, A. Urtti, Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake, J. Control. Release 158 (2011) 277-285.
80. I. Nakase, A. Tadokoro, N. Kawabata, T. Takeuchi, H. Katoh, K. Hiramoto, M. Negishi, M. Nomizu, Y. Sugiura, S. Futaki, Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis, Biochemistry 46 (2007) 492-501.
81. J.P. Richard, K. Melikov, H. Brooks, P. Prevot, B. Lebleu, L.V. Chernomordik, Cellular uptake of unconjugated Tat peptide involves clathrin-dependent endocytosis and heparan sulfate receptors, J. Biol. Chem. 280 (2005) 15300-15306.
82. M. Tyagi, M. Rusnati, M. Presta, M. Giacca, Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans, J. Biol. Chem. 276 (2001) 3254-3261.
83. N. Ram, S. Aroui, E. Jaumain, H. Bichraoui, K. Mabrouk, M. Ronjat, H. Lortat-Jacob, M. De Waard, Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine, J. Biol. Chem. 283 (2008) 24274-24284.
84. Z. Fajloun, R. Kharrat, L. Chen, C. Lecomte, E. Di Luccio, D. Bichet, M. El Ayeb, H. Rochat, P.D. Allen, I.N. Pessah, M. De Waard, J.M. Sabatier, Chemical synthesis and characterization of maurocalcine, a scorpion toxin that activates Ca(2+) release channel/ryanodine receptors, FEBS Lett. 469 (2000) 179-185.
85. H.L. Amand, C.L. Bostrom, P. Lincoln, B. Norden, E.K. Esbjorner, Binding of cellpenetrating penetratin peptides to plasma membrane vesicles correlates directly with cellular uptake, Biochim. Biophys. Acta 1808 (2011) 1860-1867.
86. J.M. Gump, R.K. June, S.F. Dowdy, Revised role of glycosaminoglycans in Tat protein transduction domain-mediated cellular transduction, J. Biol. Chem. 285 (2010) 1500-1507.
87. I.D. Alves, C. Bechara, A. Walrant, Y. Zaltsman, C.Y. Jiao, S. Sagan, Relationships between membrane binding, affinity and cell internalization efficacy of a cell-penetrating peptide: penetratin as a case study, PLoS One 6 (2011) e24096.
88. T. Letoha, A. Keller-Pinter, E. Kusz, C. Kolozsi, Z. Bozso, G. Toth, C. Vizler, Z. Olah, L. Szilak, Cell-penetrating peptide exploited syndecans, Biochim. Biophys. Acta 1798 (2010) 2258-2265.
89. S. Gerbal-Chaloin, C. Gondeau, G. Aldrian-Herrada, F. Heitz, C. Gauthier-Rouviere, G. Divita, First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actin-network remodelling, Biol. Cell 99 (2007) 223-238.
90. S.K. Bhal, K. Kassam, I.G. Peirson, G.M. Pearl, The Rule of Five revisited: applying log D in place of log P in drug-likeness filters, Mol. Pharm. 4 (2007) 556-560.
91. S. Ohkuma, B. Poole, Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents, Proc. Natl. Acad. Sci. U. S. A. 75 (1978) 3327-3331.
92. H.H. Szeto, P.W. Schiller, K. Zhao, G. Luo, Fluorescent dyes alter intracellular targeting and function of cell-penetrating tetrapeptides, FASEB J. 19 (2005) 118-120.
93. A. Mishra, G.H. Lai, N.W. Schmidt, V.Z. Sun, A.R. Rodriguez, R. Tong, L. Tang, J. Cheng, T.J. Deming, D.T. Kamei, G.C. Wong, Translocation of HIV Tat peptide and analogues induced by multiplexed membrane and cytoskeletal interactions, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 16883-16888.
94. E. Okamura, K. Ninomiya, S. Futaki, Y. Nagai, T. Kimura, C. Wakai, N. Matubayasi, Y. Sugiura, M. Nakahara, Real-time in-cell F-19 NMR study on uptake of fluorescent and nonfluorescent F-19-octaarginines into human Jurkat cells, Chem. Lett. 34 (2005) 1064-1065.
95. D. Srinivasan, N. Muthukrishnan, G.A. Johnson, A. Erazo-Oliveras, J. Lim, E.E. Simanek, J.P. Pellois, Conjugation to the cell-penetrating peptide TAT potentiates the photodynamic effect of carboxytetramethylrhodamine, PLoS One 6 (2011) e17732.
96. J.R. Maiolo III, E.A. Ottinger, M. Ferrer, Specific redistribution of cell-penetrating peptides from endosomes to the cytoplasm and nucleus upon laser illumination, J. Am. Chem. Soc. 126 (2004) 15376-15377.
97. M.P. Gillmeister, M.J. Betenbaugh, P.S. Fishman, Cellular trafficking and photochemical internalization of cell penetrating peptide linked cargo proteins: a dual fluorescent labeling study, Bioconjug. Chem. 22 (2011) 556-566.
98. T. Endoh, M. Sisido, T. Ohtsuki, Cellular siRNA delivery mediated by a cell-permeant RNA-binding protein and photoinduced RNA interference, Bioconjug. Chem. 19 (2008) 1017-1024.
99. F. Burlina, S. Sagan, G. Bolbach, G. Chassaing, A direct approach to quantification of the cellular uptake of cell-penetrating peptides using MALDI-TOF mass spectrometry, Nat. Protoc. 1 (2006) 200-205.
100. S. Aubry, F. Burlina, E. Dupont, D. Delaroche, A. Joliot, S. Lavielle, G. Chassaing, S. Sagan, Cell-surface thiols affect cell entry of disulfide-conjugated peptides, FASEB J. 23 (2009) 2956-2967.
101. I. Islam, K.Y. Ng, K.T. Chong, T.J. McQuade, J.O. Hui, K.F. Wilkinson, B.D. Rush, M.J. Ruwart, R.T. Borchardt, J.F. Fisher, Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors, J. Med. Chem. 37 (1994) 293-304.
102. D.L. Vesely, S.F. Kemp, M.J. Elders, Isolation of a biotin receptor from hepatic plasma membranes, Biochem. Biophys. Res. Commun. 143 (1987) 913-916.
103. V.K. Yellepeddi, A. Kumar, S. Palakurthi, Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro, Anticancer Res. 29 (2009) 2933-2943.
104. E.S. Lee, K. Na, Y.H. Bae, Super pH-sensitive multifunctional polymeric micelle, Nano Lett. 5 (2005) 325-329.
105. G.L. Bidwell III, D. Raucher, Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades, Expert Opin. Drug Deliv. 6 (2009) 1033-1047.
106. F. Greco, M.J. Vicent, S. Gee, A.T. Jones, J. Gee, R.I. Nicholson, R. Duncan, Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells, J. Control. Release 117 (2007) 28-39.
107. J.M. Mason, Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention, Future medicinal chemistry 2 (2010) 1813-1822.
108. I. Martín, M. Teixidó, E. Giralt, Building cell selectivity into CPP-mediated strategies, Pharmaceuticals 3 (2010) 1456-1490.
109. T. Borsello, P.G. Clarke, L. Hirt, A. Vercelli, M. Repici, D.F. Schorderet, J. Bogousslavsky, C. Bonny, A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia, Nat. Med. 9 (2003) 1180-1186.
110. L. Hirt, J. Badaut, J. Thevenet, C. Granziera, L. Regli, F. Maurer, C. Bonny, J. Bogousslavsky, D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia, Stroke 35 (2004) 1738-1743.
111. K. Inagaki, L. Chen, F. Ikeno, F.H. Lee, K. Imahashi, D.M. Bouley, M. Rezaee, P.G. Yock, E. Murphy, D. Mochly-Rosen, Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo, Circulation 108 (2003) 2304-2307.
112. D. Raucher, S. Moktan, I. Massodi, G.L. Bidwell III, Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides, Expert Opin. Drug Deliv. 6 (2009) 1049-1064.
113. S.W. Jones, R. Christison, K. Bundell, C.J. Voyce, S.M. Brockbank, P. Newham, M.A. Lindsay, Characterisation of cell-penetrating peptide-mediated peptide delivery, Br. J. Pharmacol. 145 (2005) 1093-1102.
114. C.L. Watkins, E.J. Sayers, C. Allender, D. Barrow, C. Fegan, P. Brennan, A.T. Jones, Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8, Mol. Ther. 19 (2011) 2124-2132.
115. M.M. Javadpour, M.M. Juban, W.C. Lo, S.M. Bishop, J.B. Alberty, S.M. Cowell, C.L. Becker, M.L. McLaughlin, De novo antimicrobial peptides with low mammalian cell toxicity, J. Med. Chem. 39 (1996) 3107-3113.
116. H.M. Ellerby, W. Arap, L.M. Ellerby, R. Kain, R. Andrusiak, G.D. Rio, S. Krajewski, C.R. Lombardo, R. Rao, E. Ruoslahti, D.E. Bredesen, R. Pasqualini, Anti-cancer activity of targeted pro-apoptotic peptides, Nat. Med. 5 (1999) 1032-1038.
117. L. Dutot, P. Lecorche, F. Burlina, R. Marquant, V. Point, S. Sagan, G. Chassaing, J.M. Mallet, S. Lavielle, Glycosylated cell-penetrating peptides and their conjugates to a proapoptotic peptide: preparation by click chemistry and cell viability studies, J. Chem. Biol. 3 (2009) 51-65.
118. B. Law, L. Quinti, Y. Choi, R. Weissleder, C.H. Tung, A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity, Mol. Cancer Ther. 5 (2006) 1944-1949.
119. J.C. Mai, Z. Mi, S.H. Kim, B. Ng, P.D. Robbins, A proapoptotic peptide for the treatment of solid tumors, Cancer Res. 61 (2001) 7709-7712.
120. S. Abes, J.J. Turner, G.D. Ivanova, D. Owen, D. Williams, A. Arzumanov, P. Clair, M.J. Gait, B. Lebleu, Efficient splicing correction by PNA conjugation to an R6-penetratin delivery peptide, Nucleic Acids Res. 35 (2007) 4495-4502.
121. H.M. Moulton, M.H. Nelson, S.A. Hatlevig, M.T. Reddy, P.L. Iversen, Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides, Bioconjug. Chem. 15 (2004) 290-299.
122. A. Elmquist, M. Hansen, U. Langel, Structure-activity relationship study of the cell-penetrating peptide pVEC, Biochim. Biophys. Acta 1758 (2006) 721-729.
123. J.A. Killian, G. von Heijne, How proteins adapt to a membrane-water interface, Trends Biochem. Sci. 25 (2000) 429-434.
124. O. Rekdal, B.E. Haug, M. Kalaaji, H.N. Hunter, I. Lindin, I. Israelsson, T. Solstad, N. Yang, M. Brandl, D. Mantzilas, H.J. Vogel, Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity, J. Biol. Chem. 287 (2012) 233-244.
125. W. Pham, M.F. Kircher, R. Weissleder, C.H. Tung, Enhancing membrane permeability by fatty acylation of oligoarginine peptides, Chembiochem 5 (2004) 1148-1151.
126. J.S. Lee, C.H. Tung, Lipo-oligoarginines as effective delivery vectors to promote cellular uptake, Mol. Biosyst. 6 (2010) 2049-2055.
127. A.R. Nelson, L. Borland, N.L. Allbritton, C.E. Sims, Myristoyl-based transport of peptides into living cells, Biochemistry 46 (2007) 14771-14781.
128. R. Ensenat-Waser, F. Martin, F. Barahona, J. Vazquez, B. Soria, J.A. Reig, Direct visualization by confocal fluorescent microscopy of the permeation of myristoylated peptides through the cell membrane, IUBMB Life 54 (2002) 33-36.
129. S. Futaki, W. Ohashi, T. Suzuki, M. Niwa, S. Tanaka, K. Ueda, H. Harashima, Y. Sugiura, Stearylated arginine-rich peptides: a new class of transfection systems, Bioconjug. Chem. 12 (2001) 1005-1011.
130. I. Nakase, H. Akita, K. Kogure, A. Graslund, U. Langel, H. Harashima, S. Futaki, Efficient intracellular delivery of nucleic acid pharmaceuticals using cellpenetrating peptides, Acc. Chem. Res. (2011), doi:10.1021/ar200256e.
131. H. Margus, K. Padari, M. Pooga, Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery, Mol. Ther. 20 (2012) 525-533.
132. S. Pujals, J. Fernandez-Carneado, C. Lopez-Iglesias, M.J. Kogan, E. Giralt, Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly, Biochim. Biophys. Acta 1758 (2006) 264-279.
133. H.L. Amand, B. Norden, K. Fant, Functionalization with C-terminal cysteine enhances transfection efficiency of cell-penetrating peptides through dimer formation, Biochem. Biophys. Res. Commun. 418 (2012) 469-474.
134. T. Sugita, T. Yoshikawa, Y. Mukai, N. Yamanada, S. Imai, K. Nagano, Y. Yoshida, H. Shibata, Y. Yoshioka, S. Nakagawa, H. Kamada, S. Tsunoda, Y. Tsutsumi, Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide, Biochem. Biophys. Res. Commun. 363 (2007) 1027-1032.
135. I. Neundorf, R. Rennert, J. Hoyer, F. Schramm, K. Löbner, I. Kitanovic, S. Wölfl, Fusion of a short HA2-derived peptide sequence to cell-penetrating peptides improves cytosolic uptake, but enhances cytotoxic activity, Pharmaceuticals 2 (2009) 49-65.
136. W. Li, F. Nicol, F.C. Szoka Jr., GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery, Adv. Drug Deliv. Rev. 56 (2004) 967-985.
137. I. Nakase, K. Kogure, H. Harashima, S. Futaki, Application of a fusiogenic peptide GALA for intracellular delivery, Methods Mol. Biol. 683 (2011) 525-533.